Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA)

S. Møller-Bisgaard, B. J. Ejbjerg, I. Eshed, K. Hørslev-Petersen, M. L. Hetland, A. G. Jurik, H. Thomsen, T. Torfing, K. Stengaard-Pedersen, P. Junker, N. S. Krogh, T. Lottenburger, T. Ellingsen, L. S. Andersen, H. Skjødt, A. J. Svendsen, U. Tarp, I. T. Hansen, J. Pødenphant, J. K. PedersenH. Lindegaard, Lars G. Hanson, A. Vestergaard, D. Glinatsi, M. Østergaard

    Research output: Contribution to journalJournal articleResearchpeer-review

    1 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA)'. Together they form a unique fingerprint.

    Agricultural and Biological Sciences

    Medicine and Dentistry

    Immunology and Microbiology